Journal
GYNECOLOGICAL ENDOCRINOLOGY
Volume 30, Issue 12, Pages 925-928Publisher
INFORMA HEALTHCARE
DOI: 10.3109/09513590.2014.975688
Keywords
Contraception; dienogest; lifestyle; natural-oestrogen; sexuality
Ask authors/readers for more resources
This is an observational study on 102 women aged 25-45 years to evaluate if the E2V/DNG pill has any impact on quality of life (QoL) and sexual function (FSF). Thirty-nine women were younger than 35 years (group A), and 63 women were 35 years old or older (group B). At baseline and after 6 months, patients received the Italian validated version of the Short Form-36 questionnaire and the Italian validated version of the Female Sexual Function Index questionnaire. Group A showed an overall higher perception in all QoL scores at baseline and after 6-months (p<0.05). E2V/DNG treatment did not exert any significant effect on QoL perception in group A apart from an increase in the GH domain (general health). In group B we observed a significant improvement both in GH and in VT (vitality) scores. We found a significant reduction in lubrication after 6 months both in group A and B (p<0.01) and a significant improvement in satisfaction and pain scores in group A and in desire, satisfaction and total score in group B (p<0.01). The E2V/DNG pill is associated with a significant improvement of GH and VT and with an improvement in FSF with no difference between age groups.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available